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Abstract
Diagnosis of neuropathic pain (NP) can be challenging. The ID Pain (ID-P) questionnaire,
a screening tool for NP, has been used widely both in the original version and translated
forms. The aim of this study was to develop an Arabic version of ID-P and assess its valid-
ity and reliability in detecting neuropathic pain. The original ID-P was translated in Arabic
language and administered to the study population. Reliability of the Arabic version was
evaluated by percentage observed agreement, and Cohen’s kappa; and validity by sensi-
tivity, specificity, correctly classified, and receiver operating characteristic (ROC) curve.
Physician diagnosis was considered as the gold standard for comparing the diagnostic
accuracy. The study included 375 adult patients (153 [40.8%] with NP; 222 [59.2%] with
nociceptive pain). Overall observed percentage agreement and Cohen’s kappa were
>90% and >0.80, respectively. Median (range) score of ID-P scale was 3 (2–4) and 1 (0–
2) in the NP group and NocP group, respectively (p<0.001). Area under the ROC curve
was 0.808 (95% CI, 0.764–0.851). For the cut-off value of 2, sensitivity was 84.3%,
specificity was 66.7%, and correct classification was 73.9%. Thus, the Arabic version of
ID-P showed moderate reliability and validity as a pain assessment tool. This article pres-
ents the psychometric properties of the Arabic version of ID Pain questionnaire. This Ara-
bic version may serve as a simple yet important screening tool, and help in appropriate
management of neuropathic pain, specifically in primary care centers in the Kingdom of
Saudi Arabia.
Introduction
Clinicians are often faced with the challenge of managing patients who present with chronic
pain. Accurate assessment of the type of pain is the first and the most important step for opti-
mal management of chronic pain and improving therapeutic outcome. Chronic pain can be
classified into three main categories: nociceptive pain (NocP), neuropathic pain (NP), and the
coexistence of NocP and NP, i.e., mixed pain [1, 2].
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The International Association for the Study of Pain (IASP) defines NP as “pain caused by a
lesion or disease of the somatosensory nervous system” [3, 4]. A large number of patients are
affected by chronic NP with an estimated prevalence of 6.9% to 10% [5]. Common signs and
symptoms of NP include mechanical allodynia, burning sensation, electric shock sensation,
hyperalgesia, etc. [6]. Patients with NP often suffer from difficulty in sleeping, lack of energy,
drowsiness, and difficulty in concentrating, leading to psychological distress, physical disabil-
ity, and reduced overall quality of life. As a result, NP also poses a substantial burden on the
health resources [7, 8].
Unlike NP, NocP is caused by damage to body tissues leading to activation of nociceptors.
Pathologically, it is distinguished from NP by a normal somatosensory nervous system and
clinically by a sharp, aching, or throbbing pain [9].
A pilot study conducted by Hassan et al. (2004) in 10 centers in the Middle East Region
reported the prevalence of NP as 41% and NocP as 59% in the patients with chronic low back
pain [10]. Another multicenter study conducted in 2010 to assess the prevalence of NP among
adults with lower back pain in the Arabian Gulf region found that, of the 1134 patients, 628
(55%) patients had NP. Factors associated with NP included advanced age, female gender and
diabetes with or without hypertension [11].
NP does not respond to the conventional pain treatment. However, it can be managed with
specific therapeutic agents such as tricyclic antidepressants, serotonin norepinephrine reup-
take inhibitors, antiepileptics, opioids, and topical lidocaine. [12] Therefore, it is of utmost
importance that proper evaluation of pain is carried out, so that correct diagnosis is made and
appropriate treatment is facilitated. In recent years, several standardized screening tools have
been developed to aid the identification and classification of NP on the basis of patient-
reported verbal descriptors of pain qualities [13–15]. For diagnosis of NP, numerous NP ques-
tionnaires have also gained popularity due to their high efficiency, sensitivity, and specificity.
These tools are cost-effective, do not require special equipment or examinations, and are easy
to use even by those who know little about NP [13–15].
The ID Pain questionnaire (ID-P) is a six-item screening questionnaire [16]. It includes five
sensory descriptor items and one item related to joint pain, which identifies NocP. The ID-P
tool appears to accurately indicate the presence of neuropathic component of pain. This simple
tool, which can be self-administered, could be of immense use in primary care settings [16].
The ID-P questionnaire has been translated in several languages and is widely used [16–20].
However, ID-P validation process has not been done in the Arab population. The aim of the
study was to develop an Arabic version of the ID-P and to assess its validity and reliability in
improving patient care.
Materials and methods
Study population
The study was conducted on Saudi adult patients attending pain management and diabetes
clinics at King Fahad Medical City (KFMC), a tertiary hospital in Riyadh, the central region of
Saudi Arabia, over a period of one year from March 2016 to March 2017. Patients suffering
from moderate to severe NP or NocP pain (scoring 5 or higher on a 0–10 numerical rating
scale) for at least three months were included in the study. Patients with pain of unknown ori-
gin, mixed-type pain, and diffuse pain which includes fibromyalgia syndrome, myofascial
pain, complex regional pain syndrome, cancer pain, and headaches were excluded. Also,
patients with substance abuse, chronic alcoholism, severe depression, as well as those incapable
of understanding the questionnaire were excluded.
ID Pain diagnostic questionnaire
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Ethical consideration
The study was approved by the Institutional Review Board at KFMC, Riyadh, Saudi Arabia.
Written informed consent was obtained from the participants who met inclusion criteria and
agreed to participate in the study.
Translation of the questionnaire
The adaptation procedure was monitored by a seven-member expert panel including two
specialists in pain management, an expert in methodology, an expert in clinical research,
and an expert in linguistics. The International Guidelines for Cross-Cultural Adaptation of
Health Questionnaires and Diagnostic Tests were followed [21,22]. An internationally-
accepted translation methodology was used by a well-established linguistic validation
process.
The first step was the forward translation of the questionnaire to the Arabic language by
bilingual translators, whose mother tongue was the Arabic. The first translator was informed
about the questionnaire and its applications. The second translator was neither aware nor
informed of the concepts being quantified and had no medical or clinical background. Each
translator independently produced a translated version of the questionnaire, and then the two
versions were synthesized into a single translation.
The second step was the backward translation into the original language, which was con-
ducted by two individuals with the source language (English) as their mother tongue. The two
translators were neither aware nor informed of the concepts explored, were from non-medical
background, and were totally blind to the original version.
A meeting, which included the experts and the two translator teams (forward and back
translators), was then conducted to assess the semantic and conceptual equivalence between
the original and the translated versions. The expert committee’s role was to consolidate all the
versions of the questionnaire and develop what was considered to be the pre-final version of
the questionnaire for field-testing. All the translations were, thus, reviewed by the committee
and a consensus was reached.
The final stage of adaptation process was the pretest, which involved administration of the
pre-final version of questionnaire to a sample of 30 patients (other than those included in the
validation sample) to detect potential conceptual problems. After completing the form, each
subject was interviewed to probe his/her understanding regarding each questionnaire item
and the chosen response.
Study design
Patients were divided into two groups. First group included patients diagnosed with NP by a
pain specialist in pain clinics as per the guidelines established by the IASP, [23] whereas the
second study group included patients with NocP.
The Arabic version of the ID-Pain was administered twice to the study population, by the
same investigator (S1 Questionnaire). During the first examination, the participants were
interviewed to gather information about socio-demographic and clinical characteristics, and
were asked to fill-in the ID-Pain questionnaire. All the subjects were re-evaluated two to four
hours later for second examination. The ID-P was again filled by the subjects to assess the time
stability of measurements. The assessment of the psychometric properties of the ID-Pain
focused on reliability and validity.
ID Pain diagnostic questionnaire
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Sample size estimation
Sample size was calculated assuming α = 0.05 and p = 41% with power = 0.95 and maximum
difference = 0.5. The sample size that is needed to validate the questionnaire for the two groups
was 376 patients.
Statistical analysis
Socio-demographic and clinical characteristics of patients were summarized for the whole
sample (NP group and NocP group) using frequency (%) for categorical variables and mean
(standard deviation, SD) for continuous variables. For continuous variables, normality was
assessed using Shapiro Wilk test and histograms. The socio-demographic and clinical charac-
teristics were compared between the two groups using chi-square test for categorical variables
and t-test or Mann Whitney’s U test for continuous variables.
Examining reliability of ID-P
The ID-P responses were collected in two sessions, one pre-assessment and the other post-
assessment. Therefore, for test-retest reliability of the ID-P scale, the percentage observed
agreement and Cohen’s kappa statistics were computed and reported. Intra-class-correlation
coefficient (95% confidence interval; CI) between pre- and post-ID-P scale total scores was
also computed. To check the internal consistency of the six items of the ID-P scale, Cronbach’s
α was computed for the pre- and post-measures of the scale.
Assessing validity of ID-P
Initially, median (interquartile range) of the total scores for ID-P were computed and Mann
Whitney’s U test was used to compare the scores between NP and NocP groups. Thereafter, to
assess the discriminant validity of ID-P in identifying the NP, we used receiver operating char-
acteristics curve (ROC) analyses. A binary variable with physician diagnosis of (NP = 1) versus
(NocP = 0) was created. With this binary variable, separate ROC analyses were conducted for
the total scale scores of ID-P. These ROC analyses provided the best cut-off points of the scales
total scores of ID-P with respect to the corresponding diagnostic values. For each cut-off-point
of the scores, sensitivity, specificity, correctly classified, positive likelihood ratio, negative like-
lihood ratio, were also calculated. Based on Youden’s index [24], a best cut-off-value of the
total scores of ID-P was determined, area under the ROC curve (95% CI) was computed and
reported, which determined the discriminant validity (diagnostic ability) of the total scores.
All these analyses were separately performed for the pre- and post-measure of the scales.
A statistical significance level of p<0.05 was used to reject the null hypothesis. The analyses
were conducted using statistical software of SPSS software version 17.0 (Chicago, IL, USA)
and Stata version 12 (StataCorp, Texas USA).
Results
Patient population
The study included 375 adult patients, of which 153 (40.8%; mean age: 48.4 ±12.0 years; age
range: 21–71 years) patients were diagnosed with NP and 222 (59.2%; mean age: 48.9±14.5
years; age range: 18–87 years) with NocP by expert pain physicians. Demographic and clinical
characteristics of the patients are depicted in Table 1.
The majority of NP patients had low back pain/referred pain (n = 74; 48.4%), diabetic poly-
neuropathy (n = 16; 10.5%), and lumbo-sciatic pain (n = 12; 7.8%), whereas, the majority of
ID Pain diagnostic questionnaire
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NocP patients had osteoarthritis (n = 111; 50.0%), inflammatory chronic arthritis (n = 41;
18.5%) and mechanical low back pain (n = 21; 9.5%) (Table 2).
The top three painkillers that were used by NP patients were paracetamol (n = 71; 46.4%),
meloxicam (n = 35; 22.9%), and diclofenac sodium (n = 35; 22.9%). In the NocP group, 56
(25.2%) patients used paracetamol, whereas diclofenac sodium and meloxicam were used by
40 (18.0%) and 34 (15.3%) patients, respectively.
Table 1. Comparison of the demographic and clinical characteristics of patients between neuropathic and nociceptive pain group.
Variables Neuropathic pain (n = 153); n(%) Nociceptive pain (n = 222); n(%) p-value
Gender Male 51 (33.3) 58 (26.1) 0.131
Education Level High school and above 77 (50.3) 133 (59.9) 0.066
Occupation Employed versus Unemployed 49 (32.0) 46 (20.7) 0.016
Marital Status Married 136 (88.9) 176 (79.3) 0.012
Single 13 (8.5) 24 (10.8)
Widow/Divorced 4 (2.6) 22 (9.9)
Medication use - 126 (82.4) 119 (53.6) <0.001
Comorbidities Diabetes mellitus 60 (39.2) 65 (29.3) 0.045
Hypertension 54 (35.3) 62 (27.9) 0.129
Liver disease 6 (3.9) 3 (1.4) 0.168
Heart disease 21 (13.7) 15 (6.8) 0.024
Lung disease 8 (5.2) 6 (2.7) 0.205
Kidney disease 8 (5.2) 10 (4.5) 0.747
Physical exercise 44 (28.8) 41 (18.6) 0.021
Age Years; Mean (SD) 48.4 (12.0) 48.9 (14.5) 0.721
Height cm; Mean (SD) 160.5 (10.3) 158.3 (9.2) 0.045
Weight Kg; Mean (SD) 82.0 (17.1) 78.9 (18.5) 0.138
Body mass index Kg/m2; Mean (SD) 32.0 (7.1) 31.6 (7.7) 0.665
Duration of pain Month; Mean (SD) 48 (24–84) 24 (12–48) 0.002
Significant odds ratios (OR) are in bold
https://doi.org/10.1371/journal.pone.0192307.t001
Table 2. Etiology of pain in the two study groups.
Etiology Neuropathic pain Nociceptive pain
Low back pain/Referred Pain 74 (48.4) 0 (0.0)
Diabetic polyneuropathy 16 (10.5) 0 (0.0)
Lumbosciatic pain 12 (7.8) 0 (0.0)
Peripheral neuropathy 8 (5.2) 0 (0.0)
Injury 7 (4.6) 0 (0.0)
Diabetes Painful Neuropathic Pain 3 (2.0) 0 (0.0)
Post Herpetic Neuralgia 2 (1.3) 0 (0.0)
Chronic polyradiculopathies 2 (1.3) 0 (0.0)
Trigeminal Neuralgia 1 (0.7) 0 (0.0)
Osteoarthritis 0 (0.0) 111 (50.0)
Inflammatory chronic arthritis 0 (0.0) 41 (18.5)
Mechanical low back pain 0 (0.0) 21 (9.5)
Myofascial pain 0 (0.0) 5 (2.3)
Central Neuropathic pain 0 (0.0) 1 (0.5)
Others 28 (18.3) 43 (19.4)
https://doi.org/10.1371/journal.pone.0192307.t002
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Reliability of the scale
The observed percentage agreement and Cohen’s kappa statistics computed for examining the
test-retest reliability of the pre-post assessment of the items of the ID-P scale ranged from ‘lim-
ited to joints: 93.6%, CK = 0.872’ to ‘feel like hot/burning: 97.9%, CK = 0.956’ in the overall
sample; while, it ranged from ‘feel like pins and needles: 95.4%, CK = 0.886’ to ‘feel like hot/
burning: 97.4, CK = 0.944’ in the NP group (Table 3). The intra-class correlation coefficient
(ICC) between pre- and post-ID-P scale total scores for the overall sample was 0.979 (95% CI,
0.974–0.982), whereas, for NP and NocP groups, the ICC were 0.960 (95% CI, 0.944–0.971),
and 0.976 (95% CI, 0.969–0.982), respectively. Cronbach’s α for the pre-assessment were
0.506, 0.354, and 0.446 for the overall sample, NP, and NocP respectively. Similar values of the
Cronbach’s α were observed for the post-assessment measures of the ID-P scale.
Validity of the scale
The medians (interquartile range) for the total score of ID-P scale were 3 (range, 2–4) and 1
(range, 0–2) in the NP group and NocP group, respectively (p<0.001). Using the physician
(clinical) diagnosis (NP versus NocP) as the gold standard, when the discriminant validity of
the ID-P scale was examined using the receiving operating characteristics (ROC) curve analy-
ses, the area under the ROC curve was estimated to be 0.808 (95% CI, 0.764–0.851) for ID-P
total score (Fig 1).
Further discriminant statistics (i.e., percent sensitivity, specificity, correct classification,
positive and negative likelihood ratio) for each of the possible cut-off values of the ID-P total
scores are presented in Table 4. For the cut-off value of2, the sensitivity was 84.3%, the spec-
ificity was 66.7% and the correct classification was found to be 73.9%. The positive likelihood
ratio and negative likelihood ratio were found to be 2.529 and 0.235, respectively. The adjusted
odds ratio of the clinical diagnosis of the NP for the per unit increase in the total score of ID-P
was 2.58 (95% CI, 2.02–3.28), p<0.001 (Table 5).
Table 3. Test-retest reliability (agreement between pre- and post-assessment of ID-P response) and its internal consistency.
Items of the ID-P scale Overall sample Neuropathic pain Nociceptive pain
Agreement
n (%)
Cohen’s Kappa Agreement
n (%)
Cohen’s Kappa Agreement
n (%)
Cohen’s Kappa
Feel like pins and needles 259 (95.7) 0.901 146 (95.4) 0.886 213 (96.0) 0.910
Feel like hot/burning 367 (97.9) 0.956 149 (97.4) 0.944 218 (98.2) 0.956
Feel numb 360 (96.0) 0.920 148 (96.7) 0.915 212 (95.5) 0.906
Feel like electric shocks 360 (96.0) 0.919 145 (94.8) 0.890 215 (96.9) 0.931
Made worse with the touch of clothing or bed sheets 366 (97.6) 0.932 149 (97.4) 0.937 217 (97.8) 0.924
Limited to your joints 351 (93.6) 0.872 147 (96.1) 0.738 210 (94.6) 0.864
Total scale score: test-retest reliability ICC (95% CI) ICC (95% CI) ICC (95% CI)
0.979 (0.974–0.982) 0.960 (0.944–0.971) 0.976 (0.969–0.982)
Consistency of the above 6 items scale Cronbach’s α Cronbach’s α Cronbach’s α
Pre-assessment 0.506 0.354 0.446
Post-assessment 0.531 0.272 0.461
Agreement: Observed agreement of the items of ID-P between pre- and post-assessment.
Cohen’s Kappa: Statistics for assessing test-retest reliability of each items of the scale (categorical).
ICC (95% CI): Intra class correlation coefficient (95% confidence interval) for examining test-retest reliability of the scale total score (continuous variable).
Cronbach’s α (alpha): Coefficient used to examine internal consistency of the ID-P scale
https://doi.org/10.1371/journal.pone.0192307.t003
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Discussion
The main advantages of the six-item ID-P questionnaire include its extreme brevity (takes
only few minutes to complete) and simplicity (does not require any physical examination or
assistance from physicians). Moreover, it has been found to be of high sensitivity and specific-
ity [16]. Thus, ID-P can serve as an important tool for general practitioners in the initial
screening of patients with chronic pain. Depending on the screening results, further assess-
ment can be carried out, which may subsequently influence management decisions.
In the present study, Arabic version of ID-P was developed to assess its validity and reliabil-
ity in improving patient care. In order to ascertain that the translated version accurately
reflected the original one, a robust approach was followed including a panel of experts and
bilingual translators. All the versions were then considered by the expert panel to formulate
the final version. Additionally, a pretest was carried out to ensure that the adapted version
retained its equivalence in an applied situation. The results of the present study demonstrated
Fig 1. ROC curve analysis: Plot of sensitivity versus 1-specificity (ID-P scale).
https://doi.org/10.1371/journal.pone.0192307.g001
Table 4. Discriminative characteristics of the total score for ID-P scale in identifying patients with neuropathic pain versus nociceptive pain (ROC curve analysis).
Cut-point Sensitivity (%) Specificity (%) Correctly Classified (%) LR+ LR-
(-1) 100.0 0.0 40.8 1.000
( 0) 99.4 4.1 42.9 1.035 0.161
( 1) 96.7 39.6 62.9 1.603 0.082
( 2) 84.3 66.7 73.9 2.529 0.235
( 3) 62.1 82.4 74.1 3.534 0.460
( 4) 30.7 91.4 66.7 3.589 0.758
( 5) 8.5 99.1 62.1 9.431 0.923
( 5) 0.0 100.0 59.2 1.000
Area under receiving operating characteristics (ROC) curve = 0.808 (95% CI, 0.764–0.851)
Cut-point: cut-off-value of the ID-P total scale score.
LR+: Positive likelihood ratio
LR-: Negative likelihood ratio
https://doi.org/10.1371/journal.pone.0192307.t004
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that the Arabic version of ID-P is a reliable and efficient method to detect NP. Percentage
agreement and Cohen’s kappa statistics showed that there was a high test-retest reliability of
the scale in the overall sample as well as in the two sub-groups. The intra-class correlation coef-
ficient between pre- and post-ID-P scale total scores also showed a high level of test-retest reli-
ability. Further, an area under the ROC curve of 0.808 (95% CI, 0.764–0.851) indicated a good
diagnostic value. Most importantly, the results showed a good sensitivity and moderate speci-
ficity of the Arabic version of ID-P in evaluating patients with chronic pain.
Previous translated and adapted versions of ID-P have also been validated as useful screen-
ing tools [17–20]. A cross-sectional validation study conducted on 145 (51.2%) subjects with
NP and 138 (48.8%) with NocP reported the Spanish version of ID-P as a practical, convenient,
and reliable tool for self-assessment of NP. It was found to be time stable (test-retest r-Pear-
son = 0.98; p<0.0005) with a cut -off value of3 points, area under the ROC curve of 0.89;
p<0.0005, sensitivity value of 0.81, specificity of 0.84, and kappa coefficient of agreement with
reference clinical diagnosis of 0.65 [17]. Another study conducted on 100 patients (NP, n = 24;
NocP, n = 49; mixed pain, n = 27) reported the Thai version of ID-P as an efficient method to
diagnose NP with a good predictive value (83% sensitivity, 80% specificity, area under the
ROC curve 0.890; 95% CI, 0.824–0.955) [19]. In our study, corresponding to a total score of
ID-P (cut-off)2, the Youden’s index [24] of (0.51) is maximum, but majority of the studies
[16–20] has recommended a cut-off value of3 which is consistent with a Youden’s index of
(0.45) in this study. These two indices are very close, and hence a cut-off value2 or 3 is rec-
ommended for this population. The slight variation of our results could be explained by the
difference of population in terms of ethnicity, cultural and educational background.
The high sensitivity and moderate specificity achieved in the Arabic version of the ID-P
may help in delineating the specific NP component in patients and differentiate them from
those suffering from NocP. In the Kingdom of Saudi Arabia, given the setting of primary
health care centers in far-flung areas, it is possible that patients with chronic pain are pre-
scribed inappropriate medication owing to lack of availability of pain specialists. In such a sce-
nario, ID-P can be used by a general practitioner to correctly classify the type of pain and
institute appropriate treatment. The strength of the present study lies in the fact that the Arabic
version of the questionnaire can be used by the patient himself, without any prior physical
examination and without consulting any pain physician. The present study observed all the
principles of validation. Pain physicians were involved in the study to objectively assess the
pain type through history and examination. They were also involved to compare the translated
versions of the screening tools. The testing of the subjective assessment of a patient’s pain
Table 5. Logistic regression models to adjust the effect of total scale score in predicting the physician diagnosis of
neuropathic pain.
Variables ID-P scale; OR (95% CI) p-values
Total scores 2.58 (2.02, 3.28) <0.001
Employed vs. Unemployed 2.67 (1.27, 5.59) 0.009
Marital Status 0.56 (0.31, 0.99) 0.048
Medication use 0.30 (0.15, 0.60) 0.001
Diabetes mellitus 0.75 (0.38, 1.47) 0.396
Heart disease 0.66 (0.25, 1.77) 0.410
Physical exercise 0.36 (0.18, 0.73) 0.005
Height (cm) 1.02 (0.99, 1.06) 0.145
Duration of Pain (month) 1.01 (1.00, 1.01) 0.074
https://doi.org/10.1371/journal.pone.0192307.t005
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cannot, of course, supersede the physician assessment. However, it can lead to better measures
for screening and subsequent pain management.
We used the gold standard of diagnosis based on clinical judgment by different pain spe-
cialists. However, recent recommendations among clinicians to diagnose pain with well-
defined criteria were not applied and we could not account for the variation of precise diagno-
sis in the type of pain.
In addition, a large scale epidemiologic study in the community is warranted to further sub-
stantiate the results of this study. Involvement of different centers could not be possible
because of the sheer logistics and resources involved in multicenter projects. Ideally, future
research should also address issue of reaching clinical consensus on signs and symptoms of NP
and its improved understanding for better diagnosis and treatment. This would pave a way for
the development of mechanism-based therapies.
In summary, the Arabic version of ID-P assessed in the present study had an excellent test-
retest reliability, and internal consistency of ID-P was unacceptable consistency. The face and
content validity, values for sensitivity, specificity and correct classification were also compara-
ble with the previously suggested cut-off values [17–20]. Hence, this study showed that the
Arabic version ID-P is reliable when used for the diagnosis of NP in Arabic patients.
Numerous pain diagnostic questionnaires are available for the assessment of NP. ID-P has
been used widely as an original version as well as in translated forms. The Arabic version of
ID-P has moderate reliability and validity as a pain assessment tool. The present study provides
the rationale to encourage extension of its use by general physicians to promote appropriate
pain screening in patients suffering with chronic pain. This also suggests that there is a need
for the development of local diagnostic questionnaires suited to the Arab population.
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